FDA
- Status: approved
Addition of clarithromycin to rifampicin and ethambutol (Addition of clarithromycin to rifampicin and ethambutol) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
British Thoracic Society is the originator. The local marketing authorisation holder may differ — check the official source linked above.